NSE: LTIM | BSE: 540005

Mid-range Performer

Download real time

5429.00 14.00 (0.26%)

42.79% Gain from 52W Low

214.3K NSE+BSE Volume

NSE 13 Jun, 2025 3:31 PM (IST)

160,888.1

Market Cap

High in industry

1.1

Beta 1Year

High Volatility

Analyst Buy

Sharekhan maintains a 'Buy' call on LTIMindtree; expects a revenue CAGR of 8.6% over FY26-27 See details

LTIMindtree Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LTIM, BSE:540005 LTIMindtree Ltd.

Search Inside the pdf :

LTIMindtree Ltd.

12 Jun 2025

5429.00

0.26%

Strong order inflow to aid growth

Buy: LTIMindtree Ltd.

Target

Sharekhan

We interacted with LTIMindtree’s management to understand the company’s business strategy and growth prospects. For Q1FY26, LTIMindtree expects strong order inflow to continue, bolstered by a landmark $450 million, seven-year deal, following robust order inflows of $1.68 billion in Q3FY25 and $1.6 billion in Q4FY25.

Number of FII/FPI investors increased from 548 to 562 in Mar 2025 qtr.

LTIMindtree Ltd.

06 May 2025

5429.00

0.26%

LTIMINDTREE LIMITED

Hold: LTIMindtree Ltd.

Recommendation Target

Geojit BNP Paribas

Sharekhan increased Buy price target of LTIMindtree Ltd. to 6200.0 on 12 Jun, 2025.

LTIMindtree Ltd.

24 Apr 2025

5429.00

0.26%

LTIMindtree: Q4FY25 Result Review

Buy: LTIMindtree Ltd.

Recommendation Target

IDBI Capital

LTIMindtree Ltd. has gained 21.53% in the last 3 Months

LTIMindtree Ltd.

24 Apr 2025

5429.00

0.26%

Healthcare slip impacts growth sharply

Hold: LTIMindtree Ltd.

Target

ICICI Securities Limited

LTIM reported muted performance with revenue growth down 0.6%/0.7% CC/USD QoQ, underperforming I-Sec estimates. Factors leading to slower growth were, Delayed ramp-up and deferral of deals, Ramp-down in healthcare vertical and Top-5 clients’ revenue declining from AI-led gain sharing.

LTIMindtree Ltd. is trading below its 200 day SMA of 5555.8

LTIMindtree Ltd.

24 Apr 2025

5429.00

0.26%

LTIMindtree (LTIM IN) Q4FY25 Result Update Hinting positive...

Accumulate: LTIMindtree Ltd.

Recommendation Target

Prabhudas Lilladhar

The revenue growth (-0.6% QoQ CC) was below our estimates (+0.3% QoQ CC), while margins were fairly in line, attributed to project closures and unanticipated delays in deal ramp ups. The new management is doubling down on three key initiatives to maximize revenues and improve profitability. The management expects new initiatives to start reaping benefits from Q1FY26, it expects Q1 to be a growth quarter with sequential improvement in margins. Despite having 34% dependency on tariff sensitive verticals (Manufacturing...

LTIMindtree Ltd. has an average target of 5458.20 from 10 brokers.

LTIMindtree Ltd.

23 Apr 2025

5429.00

0.26%

Muted Quarter, Gradual recovery eyed

Buy: LTIMindtree Ltd.

Target

Sharekhan

Reported revenues stood at $1,131 million, down 0.6% q-o-q/ 6.3% y-o-y in CC missing our estimates of 0.2% q-o-q growth in CC. Rupee revenues stood at Rs 9,772 crore, up 1.1% q-o-q/9.9% y-o-y.

LTIMindtree Ltd. has gained 21.53% in the last 3 Months

LTIMindtree Ltd.

23 Apr 2025

5429.00

0.26%

A weak quarter, but reset in progress

Buy: LTIMindtree Ltd.

Target

Motilal Oswal

LTIMindtree (LTIM) reported 4QFY25 revenue of USD1.1b, down 0.6% QoQ CC and below our estimate of flat QoQ CC. FY25 revenue stood at USD4.5b, up 5.0% YoY CC. 4Q EBIT margin at 13.8% was in line with our estimate of 13.8%.

LTIMindtree Ltd. is trading below its 200 day SMA of 5555.8

LTIMindtree Ltd.

29 Jan 2025

5429.00

0.26%

LTIMINDTREE LIMITED

Buy: LTIMindtree Ltd.

Recommendation Target

Geojit BNP Paribas

LTIMindtree Ltd. is trading above its 150 day SMA of 5355.1

LTIMindtree Ltd.

17 Jan 2025

5429.00

0.26%

Sub-par margin; near-term weakness in top client to weigh on growth

Sell: LTIMindtree Ltd.

Target

Emkay

LTIM reported a mixed performance in Q3FY25; revenue growth of 1.8% QoQ CC was in line with our estimate, while EBITM of 13.8% fell slightly short of our expectations.